As a follow up to our first study of 10 spinal cord injured patients, a further 8 patients were investigated over 2 months for biofilm formation on their bladder epithelial cells and for evidence that these uropathogens damage the host bladder. All the patients were found to be colonized with uropathogens, regardless of whether or not they were receiving antibiotics. Using vital staining, it was discovered that there was a significant reduction (33%) in bladder cell viability in the presence of bacterial biofilms compared to controls. This was not associated with cell turnover rates. In vitro tests showed a similar reduction in cell viability when uropathogens were incubated with bladder cells. In addition, white cell counts were significantly elevated in the patients' urine, indicative of an infectious and/or inflamed state. There was no difference between sympto matic and asymptomatic patients in their mean bacterial adhesion counts. Patients were just as likely to be symptomatic as asymptomatic when on antibiotics. In summary, the presence of virulent organisms in the bladder does adversely affect the host, even when the patient has insignificant signs and symptoms of infection, thereby raising concerns over the decision not to treat the patient. Unless specific antibiotics are used which eradicate adherent biofilms from the bladder, the treatment of symptomatic patients will only impact upon the signs and symptoms in some patients, and not alter their susceptibility to reinfection.
Introduction
The recent finding of adherent bacterial biofilms on the bladder cells of spinal cord injured (SCI) patients raises questions as to how well we understand and manage bac teriuria in these patients?! A consensus statement from the National Institute on Disability and Rehabilitation Research2 suggested that symptomatic urinary tract infection (UTI) should be treated for 7 -14 days without culture results, and that asymptomatic bacteriuria need not be treated. The scientific or clinical basis for these conclusions is not well established. As has been stated previously, the management of UTI in SCI patients should have a scientific basis. 3 Having already shown the existence of uropathogens in large numbers in biofilms on bladder cells of SCI patients, it was our hypothesis that these organisms would be damaging the host's bladder, even although the patient may present with few signs and relatively mild symptoms. The present study was undertaken to investigate this, using a group of 8 patients who had not been part of the previous study. To substantiate previous findings and to provide a baseline for this investigation, we followed the same proto col as before. However, particular attention was paid to bladder cell viability and the presence of white blood cells as indicators of damage to the uroepithelium. In vitro experiments were also carried out to deter mine the effect on cell viability of incubating uropathogens with bladder cells.
Patients and methods
Eight SCI patients who were undergoing a hospital rehabilitation program provided written consent to participate in the study, after approval of the protocol by the Park wood Hospital, London, Ontario and the University of Western Ontario Health Re view Boards. The clinical status, sex and age of the patients are shown in Table I . The p atients were using intermittent catheteriza tion for bladder management, and they p rovided urine samples via this catheter insertion over weekly intervals for 8 weeks.
During this time, they were monitored for signs and symptoms of UTI, namely, spasti city, fever, cloudy urine, and foul odour. Co-trimoxazole, in particular, was given in theory to prevent signs and symptoms from arising. Antibiotics were administered if these signs and symptoms were present and if the physician was concerned about bac terial ascension to upper tract infection. The p lanktonic organisms isolated from the bladder urine were sensitive to the antibiot ics prescribed.
A similar experimental protocol was fol lowed to that in the previous study for detection of 
Results
The results are summarized in Table I 
Discussion
The present study confirms and extends our previous findings, 1 and combined we now have evidence from 18 patients to show that bacterial biofilms could be found on 86% of bladder cells from 99 SCI patient samples. In addition, the biofilms were found in 95% of samples taken from antibiotic treated patients. Of these, 52% of the patients given antibiotics became asymptomatic. The occurrence of E. coli, K. pneumoniae and Ps. aeruginosa was not unexpected, S but the common presence of enterococcus species in the latest study was more in line with our recent e"r,Perience of outpatients attending a hospital, and those causing bacteremia in SCI patients. 7 The present study also showed a higher rate than our previous study! of samples where the urine culture was negative but the uroepithelial cells were covered with adherent bacterial biofilms (58% vs 16%).1
The comparable numbers of adherent bacteria for patients treated with antibiotics and those untreated demonstrated that the agents used did not eradicate the biofilms.
In most cases (22 of 33), trimethoprim sulfamethoxazole (co-trimoxazole) was ad ministered. The sample sizes were not large enough to compare this against other agents, but previous human studies have shown that norfloxacin can potentially erad icate infecting organisms from SCI patients, although relapses were common. 8 In vitro data have demonstrated that another fluoro quinolone, ciprofloxacin, can prevent the development of biofilms and eradicate a large percentage of biofilm organisms. 9 With the high potency of these agents, it would appear that better management can be achieved if 3 or at most 7 days therapy is used, rather than 14 days,2 if the aim is to temporarily clear the organisms from the bladder or impact on symptoms, while minimizing emergence of drug resistant organisms.
The issue of symptomatology is less clear.
Unlike the findings, albeit not verified by others, in normal adult females where bac terial adhesion appeared to correlate with symptoms,1O the adhesion counts for the SCI patients were the same whether or not signs and symptoms of infection presented. This is in agreement with our previous findings for acute, symptomatic UTI in otherwise healthy adult females, where infection arose with only a few adherent bacteria per bladder cell.l1 If the same number of bac teria were present in both groups, why does one group 'feel' or 'know' it has infection? In order to investigate possible damage to the uroepithelium, we examined the viabil ity of bladder cells from the patients. The findings were quite striking, in that a 33% loss in viability occurred compared to con trols. Half the sloughed cells were dead, although the high adhesion counts were not due to more organisms binding to the dead cells. The loss in viability occurred in symptomatic and asymptomatic patients, illustrating tissue invasion in both groups, and suggesting that other, as yet unidenti fied, host factors play an important role in causing the onset of signs and symptoms. It would be of interest to carry out cystoscopy investigations in the symptomatic UTI and asymptomatic bacteriuria SCI patients to visibly and by histochemical analyses con firm the existence of inflammation and Paraplegia 31 (1993) 494-499 tIssue damage. The high white cell counts in the urines were further testimony to appar ent tissue damage. The leukocyte results were even higher than those reported for other SCI patients, 1 2 placing the patients at an increased risk of significant morbidity. 13 The in vitro results also showed a loss in cell viability even within an hour, and suggested that bacteria and/or their by products were capable of causing bladder cells to die at a rate faster than by natural causes. The actual products responsible for this cell death were not identified, and although endotoxin may be one possible mediator,14 there are likely other factors involved, because Gram positive pathogens also inflicted cell death.
In conclusion, there is evidence to contra dict the belief that asymptomatic bacteriuria is of no consequence to the integrity of the urinary tract. 15 It would appear that the current antibiotic regimens only alter the symptomatology in some patients, but do not eradicate infecting organisms. If, as has been suggested,2 treatment is to commence without awaiting culture results, highly po tent agents, such as the fluoroquinolones, should be considered for 3-7 days duration.
If the decision is made not to treat asympto matic bacteriuria, it should be appreciated that the organisms growing in the bladder are likely conferring damage on the host. The clinical consequences of this damage remain to be determined.
It is almost certain that pathogens in biofilms will reinfect the patient at a later date. At present, there is no alternative method to manage these patients. A previ ous report of the use of avirulent organisms implanted into the bladder16 and several studies using lactobacillus implanted onto the urogenital epithelia 17 ,1 8 suggest that some infections could possibly be prevented by bacterial interference technology, if this is commercialized sometime in the future.
